Bordetella pertussis, Nasopharyngeal Culture
| Bordetella pertussis, Nasopharyngeal Culture | | | |
| Number | | 180224 |
| CPT | | 87070 |
| Related Information | | Bordetella pertussis Smear, DFA Default Test Order for Ambiguous Orders |
| Synonyms | | Bordetella pertussis Culture ; Culture, Bordetella pertussis, Nasopharyngeal ; Pertussis Culture ; Whooping Cough Culture |
| Test Includes | | Culture; isolation and identification by fluorescent antibody staining (additional charges/CPT code[s] may apply). CPT coding for microbiology and virology procedures often cannot be determined before the culture is performed. Requests with only a written order and no test number indicated will be processed according to Default Test Order for Ambiguous Orders . |
| Special Instructions | | The request form must state evaluate for Bordetella pertussis. |
| Specimen | | Nasopharyngeal swab |
| Volume | | One swab |
| Container | | Flexible swab and special charcoal-containing Bordetella transport media (available from laboratory). |
| Collection | | Guide the flexible swab into the contour of the nares and into the nasopharynx. Pass the swab gently through the nose. Leave swab in place near septum and floor of nose for 15-30 seconds. Rotate and remove. Place into special transport media available from the laboratory. |
| Storage Instructions | | If possible, preincubate at 37°C; then use refrigerated temperature for transport. |
| Patient Preparation | | Patient must not be on antimicrobial therapy. |
| Causes for Rejection | | Unlabeled specimen or name discrepancy between specimen and request label; prolonged delay in transport (usually more than 72 hours); inappropriate specimen transport device (eg, noncharcoal-containing transport medium) |
| Use | | Isolate and identify B. pertussis and B. parapertussis; establish diagnosis of whooping cough |
| Methodology | | Culture: confirmation by fluorescent antibody staining |
| Additional Information | | Direct fluorescent antibody (DFA) procedures provide more rapid results and have been increasingly used in the diagnosis of B. pertussis infection. The DFA procedures are most useful in the first 2-3 weeks of the illness. DFA test detected 42 of 164 (26%) of patients who proved culture positive for B. pertussis and 8 of 38 (21%) of patients who proved culture positive for B. parapertussis. False-negatives may be caused by inadequate specimens having little cellular material (leukocytes and brush border epithelial cells).1 Studies have shown that the best yield is obtained when DFA, culture, and PCR are used to diagnose this infection. |
| Footnotes | | - Young SA, Anderson GL, and Mitchell PD, “Laboratory Observations During an Outbreak of Pertussis,” Clin Microbiol Newslet, 1987, 9:22, 176-9
|
| References | | Gilligan PH and Fisher MC, “Importance of Culture in Laboratory Diagnosis of Bordetella pertussis Infections,” J Clin Microbiol, 1984, 20(5):891-3. Hakansson S, Sundin CG, Granstrom M, et al, “Diagnosis of Whooping Cough - A Comparison of Culture, Immunofluorescence and Serology With ELISA,” Scand J Infect Dis, 1984, 16(3):281-4. Hinman AR and Koplan JP, “Pertussis and Pertussis Vaccine. Reanalysis of Benefits, Risks, and Costs,” JAMA, 1984, 251(23):3109-13. Loeffelholz MJ, Thompson CJ, Long KS, et al, “Comparison of PCR, Culture, and Direct Fluorescent-Antibody Testing for Detection of Bordetella pertussis,” J Clin Microbiol, 1999, 37(9):2872-6. |
|